The Top Three Stocks to Watch in Asia Today

The video discusses the unexpected 16% overnight jump in Opdivo sales, a cancer drug, which reached $196 million against a forecast of less than $30 million. It also covers the performance of Yoshinoya and Yando She Holdings, highlighting Yando She's earnings surpassing guidance. The video concludes with an analysis of Lixil Group's significant financial loss, attributed to negative rate stories and pension payout calculations, despite a buy rating from Pagel.

What significant loss did Lixil group report, and how does it compare to expectations?

What action did Pagel take regarding Lixil group despite its losses?